Apply to

What’s New!

 Inpatient Buprenorphine Treatment for Opioid Use Disorder

May  23, 2023 | Presented by Nicolette Centanni, Pharm D, BCPS, BCGP, BCPP

This review will briefly describe the underlying pathophysiology of opioid use disorder and medication used to treat withdrawal and cravings. The focus of the pharmacotherapy options will be the partial opioid agonist buprenorphine. The pharmacology and pharmacokinetics of buprenorphine will be discussed in depth as well as initiation strategies for diverse clinical scenarios.

More Information

Adolescents & Young Adults ECHO: Expanding Services for OUD/SUD, Mental Health, and Other Complexities

More Information

Xylazine and Wound Care

View the Resources

Screening, Brief Intervention, and Referral to Treatment (SBIRT) Resources

View these Resources

Maine Opioid Clinical Advisory Committee Clinical Guidance Documents

View these Documents

Maine Prescription Monitoring Program (PMP)

View these Resources

Upcoming Webinars and Events

Go To Full Calendar

ME SUD Learning Community Newsletter – Read about Maine highlights, current events, upcoming opportunities, and much more in the current issue. Join our email list to receive upcoming editions in your inbox.
(Past Issues)